Results 61 to 70 of about 9,019 (165)
Table1_bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study.doc
BackgroundWe aimed to compare the detection rates of prostate cancer (PCa) and clinically significant prostate cancer(csPCa) by biparametric (bp-) and multiparameter magnetic resonance imaging (mpMRI).Materials and MethodsA total of 699 patients who ...
Dongliang Cao (512650) +8 more
core +1 more source
Review on enhancing clinical decision support system using machine learning
Abstract Clinical decision‐making is a complex patient‐centred process. For an informed clinical decision, the input data is very thorough ranging from detailed family history, environmental history, social history, health‐risk assessments, and prior relevant medical cases.
Anum Masood +4 more
wiley +1 more source
The PART randomised trial protocol: Partial Ablation versus Radical Treatment for prostate cancer
Objectives Primary objective: to determine whether prostate gland partial ablation (PA) has non‐inferior oncological treatment success vs radical treatment (RT) of localised intermediate‐risk prostate cancer (irPCa). Secondary objectives: to compare (i) participant‐reported urinary and sexual dysfunction side effects, (ii) short/medium term serious ...
Richard J. Bryant +42 more
wiley +1 more source
ABSTRACT To evaluate the influence of prostate volume on the diagnostic accuracy of multiparametric MRI (mpMRI) in detecting clinically significant prostate cancer (ISUP Grade ≥ 2), using radical prostatectomy (RP) histopathology as the reference standard.
Matthieu Bryan Chun‐Hei Mo +5 more
wiley +1 more source
IntroductionMultiparametric magnetic resonance imaging guided prostate biopsy (mpMRI PBx) leads to a higher rate of successful nerve-sparing in robot-assisted laparoscopic prostatectomy (ns-RALP) for prostate cancer (PCa).
Conrad Leitsmann +6 more
doaj +1 more source
The ‘Prostate Cancer Screening for People at Genetic Risk of Aggressive Disease’ (PATROL) study
Background Inherited (germline) pathogenic and likely pathogenic variants (gPVs) in key genes associated with increased risk of prostate cancer (PCa) now warrant more attentive PCa screening per National Comprehensive Cancer Network (NCCN) guidelines—e.g., BRCA2, HOXB13, ATM, BRCA1, MSH2, MSH6, CHEK2 and TP53.
Heather H. Cheng +12 more
wiley +1 more source
An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines [PDF]
Objectives The aim of the current report is to provide an update in the imaging interpretation of prostate cancer on multiparametric magnetic resonance imaging (mpMRI), with a special focus on how to discriminate pathological tissue from the most common ...
Francesco Giganti +8 more
core +2 more sources
The current role of prostate multiparametric magnetic resonance imaging
Prostate multi-parametric magnetic resonance imaging (mpMRI) has shown excellent sensitivity for Gleason ≥7 cancers, especially when their volume is ≥0.5 mL.
Olivier Rouviere, Paul Cezar Moldovan
doaj +1 more source
Objectives To review how response to neoadjuvant therapy (NAT) is assessed in clinical trials of muscle‐invasive bladder cancer (MIBC), and to determine whether trial‐derived evidence can inform response evaluation in contemporary practice. Subjects/Patients and Methods We searched PubMed, Embase and ClinicalTrials.gov through August 2025 for ...
Roberto Contieri +9 more
wiley +1 more source
OBJECTIVES: To evaluate if computer-aided diagnosis (CAD) prior to prostate multi-parametric MRI (mpMRI) can improve sensitivity and agreement between radiologists.
Ismail Kabakus +33 more
core +2 more sources

